Bone Biologics Corporation (BBLG) vs Genprex, Inc. (GNPX)

A side-by-side comparison of Bone Biologics Corporation and Genprex, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Bone Biologics Corporation logo
BBLG
Bone Biologics Corporation
$874595
$0.48HealthcareDelayed quote: Oct 6, 2026, 10:14 AM EDT
Genprex, Inc. logo
GNPX
Genprex, Inc.
$1M
$2.59HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT

Total return — BBLG vs GNPX

growth of $100 · dividends reinvested · last 5y
BBLG -100.0% (-82.9%/yr)GNPX -100.0% (-88.1%/yr)BBLG compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $10020222023202420252026$0$0
BBLG GNPX

BBLG vs GNPX: by the numbers

  • •GNPX is the larger company ($1M vs $874595 market cap).

Metrics side by side

Valuation

MetricBBLGGNPX
P/B ratio0.220.09

Profitability

MetricBBLGGNPX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-73.66%-111.51%
ROIC-78.01%-107.08%

Growth (annualized)

MetricBBLGGNPX
Total return CAGR (5Y)N/A-88.16%

Go deeper

Full BBLG analysisFull GNPX analysisInteractive comparison tool

Dig into the metrics

Bone Biologics ROEGenprex ROEBone Biologics operating marginGenprex operating marginBone Biologics revenue growthGenprex revenue growthBone Biologics free cash flowGenprex free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.